Page last updated: 2024-11-02

piribedil and Pituitary Neoplasms

piribedil has been researched along with Pituitary Neoplasms in 1 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sarkar, DK1
Gottschall, PE1
Meites, J1

Other Studies

1 other study available for piribedil and Pituitary Neoplasms

ArticleYear
Decline of tuberoinfundibular dopaminergic function resulting from chronic hyperprolactinemia in rats.
    Endocrinology, 1984, Volume: 115, Issue:4

    Topics: Animals; Dopamine; Electric Stimulation; Female; Median Eminence; Neurons; Piribedil; Pituitary Glan

1984